TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 9 | -7 | 4 | 28 | 53 | 54 | 24 | 
| P | %wins | 100 | 0 | 100 | 100 | 100 | 100 | 83 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/31/19 18:28  | 5/31/19  | TLGT | Teligent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gale James C | NJ | D | P | 13 | 0.6583 | 0 | 20 | 5 | 420 | D | |||||||||||||||
5/24/19 08:00  | 5/23/19  | TLGT | Teligent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gale James C | NJ | D | P | 14 | 0.6907 | 0 | 20 | 5 | 400 | D | |||||||||||||||
11/13/17 17:01  | 11/10/17  | TLGT | Teligent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gale James C | NY | D | P | 57 | 3.81 | 0 | 15 | 4 | 380 | D | |||||||||||||||
3/14/16 08:31  | 3/11/16  | TLGT | Teligent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gale James C | NY | DT | P | 74 | 4.91 | 2 | 15 | 30 | 65 | I | -41 | -31 | -18 | -22 | -14 | 9 | -7 | 4 | 28 | 53 | 54 | ||||
5/1/15 13:22  | 4/30/15  | IG | Igi Laboratories, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Gale James C | NY | DT | P | 151 | 5.04 | 0 | 30 | 51 | 89 | M | |||||||||||||||
8/26/14 13:22  | 8/22/14  | IG | Igi Laboratories, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Gale James C | NY | DT | P | 30 | 5.90 | 0 | 5 | 34 | 20 | D | |||||||||||||||
3/15/13 10:52  | 3/13/13  | IG | Igi Laboratories, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Gale James C | NY | DT | P.d | 13 | 1.33 | 0 | 10 | 216 | 15 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |